Typically, only one in ten experimental vaccines make it all the way through to regulatory approval. Therefore, different approaches mean the chances of success are higher. At present only one vaccine has entered the human trials stage and about 8-10 are nearing that milestone. The rest are still in pre-clinical stage. Normally, just one of every ten exploratory antibodies...
- 2 days ago